Form 4 for ANTX AN2 Therapeutics, Inc.
Accepted 2026-09-16 17:35:25 ET · period of report 2026-09-15 · accession 0001193125-26-393274 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-16 17:35 | 2026-09-15 | ANTX | Trenor Cameron C. III | Chief Medical Off | A - Grant | $0.00 | +116.7K | 116.7K | New | $0 |
| D | 2026-09-16 17:35 | 2026-09-15 | ANTX | Trenor Cameron C. III | Chief Medical Off | A - Grant | $0.00 | +233.3K | 233.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-15 | A | A | 116,667 | $0.00 | 116,667 | D | — | — | (F1) Represents restricted stock units ("RSUs") which vest as follows: 10,400 RSUs vest on January 1, 2027, prorated from August 24, 2026, the vesting start date, and the remaining RSUs vest in equal annual installments on each January 1, 2028, January 1, 2029 and January 1, 2030, subject to the Reporting Person's continuous service through each applicable vesting date. |
| 2 | Derivative | Stock Option (right to by) | 2026-09-15 | A | A | 233,333 | $0.00 | 233,333 | D | $5.36 · — to 2036-09-14 | 233,333 Common Stock | (F2) The shares subject to the stock option vest as follows: 25% of the shares vest on August 24, 2027 and the remaining shares vest in equal monthly installments over the subsequent 36 months, subject to the Reporting Person's continuous service through each applicable vesting date. |